[go: up one dir, main page]

BR9815098A - Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal. - Google Patents

Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.

Info

Publication number
BR9815098A
BR9815098A BR9815098-7A BR9815098A BR9815098A BR 9815098 A BR9815098 A BR 9815098A BR 9815098 A BR9815098 A BR 9815098A BR 9815098 A BR9815098 A BR 9815098A
Authority
BR
Brazil
Prior art keywords
mirtazapine
treatment
animal
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
BR9815098-7A
Other languages
English (en)
Inventor
John Stuart Andrews
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9815098A publication Critical patent/BR9815098A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

''USO DE MIRTAZAPINA OU DE UM SEU SAL FARMACEUTICAMENTE ACEITáVEL, E, PROCESSO PARA O TRATAMENTO DE APNéIAS DO SONO EM UM ANIMAL'' O composto mirtazapina é verificado como sendo efetivo no tratamento de apnéias do sono. Opcionalmente mirtazapina é combinada com um SSRI tal como fluoxetina.
BR9815098-7A 1997-11-14 1998-11-13 Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal. BR9815098A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (1)

Publication Number Publication Date
BR9815098A true BR9815098A (pt) 2000-10-10

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815098-7A BR9815098A (pt) 1997-11-14 1998-11-13 Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.

Country Status (20)

Country Link
US (1) US6303595B1 (pt)
EP (1) EP1030667B1 (pt)
JP (1) JP2001522891A (pt)
KR (1) KR20010032009A (pt)
CN (1) CN1154495C (pt)
AT (1) ATE289816T1 (pt)
AU (1) AU737590B2 (pt)
BR (1) BR9815098A (pt)
CA (1) CA2309744A1 (pt)
CZ (1) CZ296282B6 (pt)
DE (1) DE69829202T2 (pt)
DK (1) DK1030667T3 (pt)
ES (1) ES2238781T3 (pt)
HU (1) HUP0100080A3 (pt)
IL (2) IL135825A0 (pt)
NO (1) NO20002218L (pt)
PL (1) PL192272B1 (pt)
PT (1) PT1030667E (pt)
TR (1) TR200001293T2 (pt)
WO (1) WO1999025356A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
ES2267253T3 (es) 1998-02-27 2007-03-01 The Board Of Trustees Of The University Of Illinois Agentes con actividad relacionada con la serotonina para el tratamiento de la apnea del sueño.
HUP0204391A3 (en) * 2000-02-11 2005-03-29 Akzo Nobel Nv The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP1667972B1 (en) 2003-09-10 2013-06-19 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
JP2008524332A (ja) 2004-12-20 2008-07-10 コレジウム ファーマシューティカル， インク． 睡眠傷害のための医薬組成物
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
US10172920B2 (en) 2012-06-14 2019-01-08 The Regents Of The University Of Michigan Sleep apnea treatment
ES2874549T3 (es) 2015-02-27 2021-11-05 Dechra Ltd Estimulación del apetito, control de la pérdida de peso, y tratamiento de la anorexia en perros y gatos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
PT866711E (pt) * 1995-10-24 2006-12-29 Gruenenthal Gmbh Montirelina para inibição da apneia do sono
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
AU737590B2 (en) 2001-08-23
WO1999025356A1 (en) 1999-05-27
PT1030667E (pt) 2005-06-30
CN1278731A (zh) 2001-01-03
ATE289816T1 (de) 2005-03-15
CZ20001751A3 (cs) 2000-10-11
HUP0100080A3 (en) 2002-05-28
EP1030667A1 (en) 2000-08-30
NO20002218D0 (no) 2000-04-28
TR200001293T2 (tr) 2002-09-23
CN1154495C (zh) 2004-06-23
US6303595B1 (en) 2001-10-16
IL135825A0 (en) 2001-05-20
IL135825A (en) 2006-12-31
DE69829202D1 (de) 2005-04-07
NO20002218L (no) 2000-05-12
HUP0100080A2 (hu) 2001-08-28
JP2001522891A (ja) 2001-11-20
ES2238781T3 (es) 2005-09-01
AU1754899A (en) 1999-06-07
PL192272B1 (pl) 2006-09-29
CZ296282B6 (cs) 2006-02-15
HK1029932A1 (en) 2001-04-20
CA2309744A1 (en) 1999-05-27
DK1030667T3 (da) 2005-06-20
KR20010032009A (ko) 2001-04-16
DE69829202T2 (de) 2005-07-21
EP1030667B1 (en) 2005-03-02
PL340467A1 (en) 2001-02-12

Similar Documents

Publication Publication Date Title
BR9815098A (pt) Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
IL182908A (en) Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
BR9810554A (pt) Aroil piperazinas para regular a atividade sexual
FI920324A7 (fi) Valmiste sellaisten vaikuttavien aineiden kontrolloituun vapautumiseen, jotka sopivat terapeuttisiksi aineiksi tai parantamaan kasvua ja ruoan hyväksikäyttöä märehtijöillä
CU23367A3 (es) Formulación de moxifloxacino con sal común
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
HUP0200969A3 (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders os mixed anxiety-depression disorders
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
CN204500169U (zh) 一种婴儿枕
BR0213434A (pt) Método para evitar demência em um paciente, e, uso de rosuvastatina ou seu sal farmaceuticamente aceitável
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
BR0107211A (pt) Agente para tratar hepatite c
BR0112874A (pt) Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/55, A61P 11/16

Ipc: A61K 31/55 (2008.04), A61P 11/16 (2008.04)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.